Journal article
Commentary. Are patients receiving maximal medical therapy following carotid endarterectomy?
Perspectives in vascular surgery and endovascular therapy, Vol.17(3), pp.272-273
09/2005
DOI: 10.1177/153100350501700322
PMID: 16273179
Abstract
The authors used clams data from Blue Cross and Blue Shield Michigan for a 3-year period to study usage of antihypertensive and antiplatelet agents. and statins, after carotid endarterectomy and compared it with results from the North American Symptomatic Carotid Endarterectormy Trial (NASCET). Prescription of drugs and use for a sustained 1- year period was exam ned. They found the statin prescription rate was 70%, 66%, and 73%6 for the 3 study years and the average sustained statin use was 38%. Use of antiplatelet medications (5%) and angiotensin-converting enzyme inhibitors (19%) was aiso low. The authors concluded that statin use has ncreased after carotid endarterectomy compared with NASCET but remains below 40%.
Details
- Title: Subtitle
- Commentary. Are patients receiving maximal medical therapy following carotid endarterectomy?
- Creators
- William J Sharp - Division of Vascular Surgery, University of Iowa Health Care, 200 Hawkins Drive, Iowa City, 52242, USATimothy F Kresowik
- Resource Type
- Journal article
- Publication Details
- Perspectives in vascular surgery and endovascular therapy, Vol.17(3), pp.272-273
- Publisher
- United States
- DOI
- 10.1177/153100350501700322
- PMID
- 16273179
- ISSN
- 1531-0035
- eISSN
- 1521-5768
- Language
- English
- Date published
- 09/2005
- Academic Unit
- Radiology; Surgery
- Record Identifier
- 9984051999402771
Metrics
9 Record Views